Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine
暂无分享,去创建一个
[1] J. Beier,et al. Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. , 1991, The American journal of tropical medicine and hygiene.
[2] Myron M. Levine,et al. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites , 1987, Nature.
[3] P. V. Perkins,et al. Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. , 1994, The American journal of tropical medicine and hygiene.
[4] A. Moreno,et al. CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. , 1993, Journal of immunology.
[5] J. Vanderberg,et al. Immunization of man against sporozite-induced falciparum malaria , 1973, The American journal of the medical sciences.
[6] A. Moreno,et al. Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. , 1991, International immunology.
[7] Patricia De la Vega,et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.
[8] S. Hoffman,et al. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. , 1995, Journal of immunology.
[9] S. Hoffman,et al. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. , 1987, Science.
[10] D. Clyde,et al. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. , 1975, The American journal of tropical medicine and hygiene.
[11] Clyde Df. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. , 1990 .
[12] P. Nguyen-Dinh,et al. Plasmodium falciparum gametocytes from culture in vitro develop to sporozoites that are infectious to primates. , 1982, Science.
[13] S. Hoffman,et al. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Conway,et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial , 2001, The Lancet.
[15] S. Hoffman,et al. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. , 1993, The American journal of tropical medicine and hygiene.
[16] J. Vanderberg,et al. Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei , 1967, Nature.
[17] M. Hilleman. Yeast recombinant hepatitis B vaccine , 2005, Infection.
[18] I. Schneider,et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. , 1995, Journal of immunology.
[19] E. Nardin. T cell responses in a sporozoite-immunized human volunteer and a chimpanzee. , 1990, Immunology letters.
[20] D. Clyde. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. , 1990, Bulletin of the World Health Organization.
[21] S. Hoffman. Malaria vaccine development: a multi-immune response approach , 1996 .
[22] R. Miller,et al. Specificity of protection of man immunized against sporozoite‐induced falciparum malaria , 1973, The American journal of the medical sciences.
[23] S L Hoffman,et al. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. , 1997, The Journal of infectious diseases.
[24] S. Hoffman,et al. Malaria--from Infants to Genomics to Vaccines , 2002, Science.
[25] V. Nussenzweig,et al. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. , 1980, Science.
[26] J. Palensky,et al. Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria. , 2001, The Journal of infectious diseases.
[27] J. Haynes,et al. Culture of human malaria parasites Plasmodium falciparum , 1976, Nature.
[28] V. Nussenzweig,et al. Rationale for the development of an engineered sporozoite malaria vaccine. , 1989, Advances in immunology.
[29] K. Sell,et al. Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. , 1974, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[30] D. Clyde,et al. Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man. , 1977, Experimental parasitology.
[31] D. Herrington,et al. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. , 1991, The American journal of tropical medicine and hygiene.
[32] R W Chesnut,et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.
[33] S. Hoffman,et al. Perspectives on malaria vaccine development. , 1996 .
[34] K. Rieckmann,et al. Human immunization with attenuated sporozoites. , 1990, Bulletin of the World Health Organization.
[35] P. Barr,et al. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. , 1990, Bulletin of the World Health Organization.
[36] S. Hoffman,et al. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. , 1986, The American journal of tropical medicine and hygiene.
[37] P. Caspers,et al. Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. , 1989, Science.
[38] J. Weber,et al. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. , 1984, Science.
[39] S. Hoffman,et al. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] G. Wortmann,et al. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. , 1998, The Journal of infectious diseases.
[41] S. Hoffman,et al. Attacking the infected hepatocyte. , 1996 .
[42] John Sidney,et al. HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles1 2 , 2000, The Journal of Immunology.
[43] K. Sell,et al. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. , 1979, Bulletin of the World Health Organization.
[44] S. Hoffman,et al. Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. , 2001, The American journal of tropical medicine and hygiene.
[45] G Losonsky,et al. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. , 1993, The Journal of infectious diseases.
[46] S. Hoffman. Experimental Challenge of Volunteers with Malaria , 1997, Annals of Internal Medicine.
[47] W. Trager,et al. Human malaria parasites in continuous culture. , 1976, Science.
[48] S. Hoffman,et al. Seasonal malaria attack rates in infants and young children in northern Ghana. , 2002, The American journal of tropical medicine and hygiene.
[49] S. Hoffman,et al. SAFETY AND EFFICACY OF A RECOMBINANT DNA PLASMODIUM FALCIPARUM SPOROZOITE VACCINE , 1987, The Lancet.
[50] T. Richie,et al. Progress and challenges for malaria vaccines , 2002, Nature.
[51] S. Hoffman,et al. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2 , 1995, The Journal of experimental medicine.